G David Roodman1. 1. Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh, School of Medicine/Hematology, the University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA. roodmangd@msx.upmc.edu
Authors: Avi Schroeder; Daniel A Heller; Monte M Winslow; James E Dahlman; George W Pratt; Robert Langer; Tyler Jacks; Daniel G Anderson Journal: Nat Rev Cancer Date: 2011-12-23 Impact factor: 60.716
Authors: Dali Zheng; Keith F Decker; Tianhua Zhou; Jianquan Chen; Zongtai Qi; Kathryn Jacobs; Katherine N Weilbaecher; Eva Corey; Fanxin Long; Li Jia Journal: Mol Cancer Res Date: 2013-02-05 Impact factor: 5.852
Authors: Jian Yu Xu; William A Murphy; Denái R Milton; Camilo Jimenez; Sarika N Rao; Mouhammed Amir Habra; Steven G Waguespack; Ramona Dadu; Robert F Gagel; Anita K Ying; Maria E Cabanillas; Steven P Weitzman; Naifa L Busaidy; Rena V Sellin; Elizabeth Grubbs; Steven I Sherman; Mimi I Hu Journal: J Clin Endocrinol Metab Date: 2016-09-23 Impact factor: 5.958